Shengyang Liu

机构：Shandong University, Shandong Provincial Hospital

发表论文 28 篇 · 总被引 215 次 · h-index 9

代表论文

• Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial (2023 · EClinicalMedicine · 被引 61)
• Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps (2025 · JAMA · 被引 24)
• Oxidative stress and reactive oxygen species in otorhinolaryngological diseases: insights from pathophysiology to targeted antioxidant therapies (2025 · Redox Report · 被引 22)
• The multifaceted mechanisms of Dihydrotanshinone I in the treatment of tumors (2024 · Biomedicine & Pharmacotherapy · 被引 18)
• Research progress of traditional Chinese medicine in the treatment of allergic rhinitis (2024 · Heliyon · 被引 17)
• An Integrated Analysis of Inflammatory Endotypes and Clinical Characteristics in Chronic Rhinosinusitis with Nasal Polyps (2022 · Journal of Inflammation Research · 被引 17)